Disparities Exist in Delivering Innovative Cancer Therapies
How can disparities be mitigated when it comes to giving patients the newest and most innovative cancer treatments?
Delivering new and innovative cancer therapies, such as CAR T-cell therapy, come with disparities, explained John Sweetenham, MD, FACP, FRCP, director of clinical affairs and physician in chief at Huntsman Cancer Institute, University of Utah, in Salt Lake City.
These disparities go beyond those that first come to mind, such as race and ethnicity. Patients face barriers in entering clinical trials and receiving the latest standard of care if they live in rural areas.
Three aspects could help fix this problem, said Sweetenham: more education about new advances; more robust funding systems; and a more sophisticated technological platform for clinicians to communicate with patients.
Shared Model of Care Post-HCT Offers Safe Follow-Up, Reduces Patient Burden
Published: March 19th 2025 | Updated: March 19th 2025Alternating post-HCT care between specialized facilities and local cancer centers produced noninferior non-relapse mortality and similar quality of life to usual care.
